Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$45.30 +1.6%	$50.99	$42.25 ▼ $109.50	$67.33B	0.58	18.24 million shs	13.00 million shs
DXCM DexCom	$73.57 +1.6%	$68.50	$54.11 ▼ $89.98	$28.39B	1.45	5.33 million shs	5.57 million shs
SYK Stryker	$330.27 +1.7%	$309.80	$281.00 ▼ $404.87	$126.61B	0.77	2.36 million shs	2.48 million shs
XLV Health Care Select Sector SPDR Fund	$164.44 +1.5%	$150.13	$127.96 ▼ $165.61	$42.17B	0.56	12.48 million shs	12.12 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	-1.10%	+2.60%	-8.36%	-27.88%	-57.25%
DXCM DexCom	+1.59%	+3.43%	-0.66%	+14.69%	-12.51%
SYK Stryker	-0.55%	-1.71%	+6.19%	-2.12%	-17.19%
XLV Health Care Select Sector SPDR Fund	-1.09%	+0.76%	+5.85%	+10.50%	+19.53%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$45.30 +1.6%	$50.99	$42.25 ▼ $109.50	$67.33B	0.58	18.24 million shs	13.00 million shs
DXCM DexCom	$73.57 +1.6%	$68.50	$54.11 ▼ $89.98	$28.39B	1.45	5.33 million shs	5.57 million shs
SYK Stryker	$330.27 +1.7%	$309.80	$281.00 ▼ $404.87	$126.61B	0.77	2.36 million shs	2.48 million shs
XLV Health Care Select Sector SPDR Fund	$164.44 +1.5%	$150.13	$127.96 ▼ $165.61	$42.17B	0.56	12.48 million shs	12.12 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	-1.10%	+2.60%	-8.36%	-27.88%	-57.25%
DXCM DexCom	+1.59%	+3.43%	-0.66%	+14.69%	-12.51%
SYK Stryker	-0.55%	-1.71%	+6.19%	-2.12%	-17.19%
XLV Health Care Select Sector SPDR Fund	-1.09%	+0.76%	+5.85%	+10.50%	+19.53%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	2.80	Moderate Buy	$82.12	81.44% Upside
DXCM DexCom	2.89	Moderate Buy	$84.88	15.54% Upside
SYK Stryker	2.73	Moderate Buy	$395.10	20.87% Upside
XLV Health Care Select Sector SPDR Fund	2.76	Moderate Buy	$164.50	0.30% Upside

Current Analyst Ratings Breakdown

Latest SYK, BSX, DXCM, and XLV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/6/2026	SYK Stryker	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$350.00
7/6/2026	BSX Boston Scientific	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$65.00
6/25/2026	BSX Boston Scientific	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$75.00 ➝ $65.00
6/24/2026	BSX Boston Scientific	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$100.00 ➝ $67.00
6/23/2026	DXCM DexCom	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/23/2026	DXCM DexCom	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$86.00
6/16/2026	BSX Boston Scientific	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$65.00
6/15/2026	DXCM DexCom	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$75.00 ➝ $88.00
6/12/2026	BSX Boston Scientific	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$65.00
6/10/2026	DXCM DexCom	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$95.00
6/10/2026	DXCM DexCom	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$75.00 ➝ $95.00

(Data available from 7/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$20.07B	3.35	$4.04 per share	11.19	$16.49 per share	2.74
DXCM DexCom	$4.66B	6.08	$2.86 per share	25.73	$7.04 per share	10.43
SYK Stryker	$25.12B	4.99	$16.91 per share	19.33	$58.63 per share	5.58
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$2.90B	$2.39	18.94	12.23	0.86	17.29%	19.17%	10.77%	7/29/2026 (Estimated)
DXCM DexCom	$836.30M	$2.34	31.42	24.09	1.17	19.31%	33.33%	13.19%	7/29/2026 (Estimated)
SYK Stryker	$3.25B	$8.64	37.83	19.71	2.09	13.20%	23.42%	11.04%	7/30/2026 (Estimated)
XLV Health Care Select Sector SPDR Fund	N/A	N/A	21.15	N/A	N/A	N/A	N/A	N/A	N/A

Latest SYK, BSX, DXCM, and XLV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2026	Q2 2026	SYK Stryker	$3.49	N/A	N/A	N/A	$6.58 billion	N/A
7/29/2026	Q2 2026	BSX Boston Scientific	$0.83	N/A	N/A	N/A	$5.37 billion	N/A
7/29/2026	Q2 2026	DXCM DexCom	$0.61	N/A	N/A	N/A	$1.29 billion	N/A
4/30/2026	Q1 2026	DXCM DexCom	$0.47	$0.56	+$0.09	$0.51	$1.17 billion	$1.19 billion
4/30/2026	Q1 2026	SYK Stryker	$2.98	$2.60	-$0.38	$1.93	$6.34 billion	$6.02 billion
4/22/2026	Q1 2026	BSX Boston Scientific	$0.7930	$0.80	+$0.0070	$0.90	$5.19 billion	$5.20 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
DXCM DexCom	N/A	N/A	N/A	N/A	N/A
SYK Stryker	$3.52	1.08%	+7.58%	40.74%	32 Years
XLV Health Care Select Sector SPDR Fund	$2.53	1.54%	N/A	N/A	N/A

Latest SYK, BSX, DXCM, and XLV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2026	SYK Stryker	quarterly	$0.88	1.12%	6/30/2026	6/30/2026	7/31/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.42	1.90	1.22
DXCM DexCom	0.42	1.95	1.64
SYK Stryker	0.62	2.11	1.25
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
DXCM DexCom	97.75%
SYK Stryker	77.09%
XLV Health Care Select Sector SPDR Fund	N/A

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.34%
DXCM DexCom	0.28%
SYK Stryker	4.60%
XLV Health Care Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	59,000	1.49 billion	1.48 billion	Optionable
DXCM DexCom	11,000	385.87 million	384.79 million	Optionable
SYK Stryker	56,000	383.36 million	365.73 million	Optionable
XLV Health Care Select Sector SPDR Fund	N/A	256.42 million	N/A	Not Optionable

SYK, BSX, DXCM, and XLV Headlines

Recent News About These Companies

Weak June Jobs Data Likely to Boost These ETF Areas

July 6 at 12:00 PM | zacks.com

State Street Health Care ETF Tops Invesco Pharma on Cost and Size

July 4 at 11:45 AM | fool.com

Health Care Select Sector SPDR Fund (NYSEARCA:XLV) Reaches New 12-Month High - Time to Buy?

July 4 at 3:25 AM | americanbankingnews.com

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

July 2, 2026 | aol.comA

Anxious About an AI Bubble? ETFs to Help Navigate the Risk

June 30, 2026 | zacks.com

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

June 29, 2026 | zacks.com

Health Care Select Sector SPDR ETF declares quarterly distribution of $0.6563

June 22, 2026 | msn.com

ETF Ways to Navigate the 2026 Midterm Election Cycle

June 22, 2026 | zacks.com

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?

June 22, 2026 | zacks.com

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

June 21, 2026 | 247wallst.com

3 Ridiculously Cheap Healthcare Stocks to Buy in June

June 13, 2026 | 247wallst.com

Health care breadth thrust points to sector rotation

June 11, 2026 | seekingalpha.com

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

June 11, 2026 | etftrends.comE

ETFs That May Provide Investors Protection From Market Risks

June 10, 2026 | zacks.com

Likely Sector ETF & Stock Winners From May Jobs Report

June 10, 2026 | zacks.com

Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike

June 9, 2026 | zacks.com

No tech, no problem. Dow makes record and traders think these stocks can lead now

June 5, 2026 | cnbc.com

UnitedHealth, Eli Lilly lead healthcare rankings as sector gains momentum

June 5, 2026 | seekingalpha.com

Too Much Tech in Your Portfolio? ETFs to Help You Diversify

June 5, 2026 | zacks.com

Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors.

June 5, 2026 | fool.com

These Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)

...

May 18, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SYK, BSX, DXCM, and XLV Company Descriptions

Boston Scientific NYSE:BSX

$45.30 +0.70 (+1.56%)

Closing price 03:59 PM Eastern

Extended Trading

$45.27 -0.03 (-0.06%)

As of 07:03 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

DexCom NASDAQ:DXCM

$73.57 +1.19 (+1.64%)

Closing price 04:00 PM Eastern

Extended Trading

$73.08 -0.49 (-0.67%)

As of 07:05 PM Eastern

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Stryker NYSE:SYK

$330.26 +5.54 (+1.70%)

Closing price 03:59 PM Eastern

Extended Trading

$328.20 -2.07 (-0.63%)

As of 06:51 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$164.44 +2.48 (+1.53%)

Closing price 04:10 PM Eastern

Extended Trading

$164.44 0.00 (0.00%)

As of 07:05 PM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SYK, BSX, DXCM, and XLV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SYK, BSX, DXCM, and XLV Earnings

Compare Dividends

Latest SYK, BSX, DXCM, and XLV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SYK, BSX, DXCM, and XLV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SYK, BSX, DXCM, and XLV Company Descriptions

Boston Scientific NYSE:BSX

DexCom NASDAQ:DXCM

Stryker NYSE:SYK

Health Care Select Sector SPDR Fund NYSEARCA:XLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools